Targeting TIM-3 for hematological malignancy: latest updates from the 2022 ASH annual meeting
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Targeting TIM-3 for hematological malignancy: latest updates from the 2022 ASH annual meeting ; volume:12 ; number:1 ; day:19 ; month:7 ; year:2023 ; pages:1-4 ; date:12.2023
Experimental hematology & oncology ; 12, Heft 1 (19.7.2023), 1-4, 12.2023
- Urheber
-
Tan, Jiaxiong
Tan, Huo
Li, Yangqiu
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40164-023-00421-2
- URN
-
urn:nbn:de:101:1-2023102513024461818088
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tan, Jiaxiong
- Tan, Huo
- Li, Yangqiu
- SpringerLink (Online service)
Ähnliche Objekte (12)
Dual-targeted CAR T-cell immunotherapies for hematological malignancies: latest updates from the 2023 ASH annual meeting
The role of BCL11B in hematological malignancy
Immunogenic Cell Death in Hematological Malignancy Therapy
Chryseobacterium indologenes: An emerging uropathogen among hematological malignancy patients
Management strategy for hematological malignancy patients with acute respiratory failure
Mosunetuzumab and lymphoma: latest updates from 2022 ASH annual meeting
HIV associated lymphoma: latest updates from 2023 ASH annual meeting
Differentiating central nervous system infection from disease infiltration in hematological malignancy
Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan
A Rare Occurrence of Solid Gynecological Malignancy Synchronous with Hematological Malignancy: Rare Case and Review of Literature
Pediatric hematological malignancy: Identification of issues involved in the road to diagnosis
CAR-NK cell therapy for hematological malignancies: recent updates from ASH 2022
Dual-targeted CAR T-cell immunotherapies for hematological malignancies: latest updates from the 2023 ASH annual meeting
The role of BCL11B in hematological malignancy
Immunogenic Cell Death in Hematological Malignancy Therapy
Chryseobacterium indologenes: An emerging uropathogen among hematological malignancy patients
Management strategy for hematological malignancy patients with acute respiratory failure
Mosunetuzumab and lymphoma: latest updates from 2022 ASH annual meeting
HIV associated lymphoma: latest updates from 2023 ASH annual meeting
Differentiating central nervous system infection from disease infiltration in hematological malignancy
Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan
A Rare Occurrence of Solid Gynecological Malignancy Synchronous with Hematological Malignancy: Rare Case and Review of Literature
Pediatric hematological malignancy: Identification of issues involved in the road to diagnosis
CAR-NK cell therapy for hematological malignancies: recent updates from ASH 2022
Dual-targeted CAR T-cell immunotherapies for hematological malignancies: latest updates from the 2023 ASH annual meeting
The role of BCL11B in hematological malignancy
Immunogenic Cell Death in Hematological Malignancy Therapy
Chryseobacterium indologenes: An emerging uropathogen among hematological malignancy patients
Management strategy for hematological malignancy patients with acute respiratory failure
Mosunetuzumab and lymphoma: latest updates from 2022 ASH annual meeting
HIV associated lymphoma: latest updates from 2023 ASH annual meeting
Differentiating central nervous system infection from disease infiltration in hematological malignancy
Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan
A Rare Occurrence of Solid Gynecological Malignancy Synchronous with Hematological Malignancy: Rare Case and Review of Literature
Pediatric hematological malignancy: Identification of issues involved in the road to diagnosis